Mark Roe

Mark is a partner in the corporate group at eversheds sutherland's london office. Mark has a broad range of corporate experience having acted on m&a (private and public), equity capital markets and listed/quoted company transactions, joint venture and other corporate transactions.Mark's recent experience includes acting for:dimension data holdings plc on its takeover by ntt for £2.1 billion;nestor healthcare group plc on its £124 million takeover by saga group limited;alere inc. On its £235 million recommended (initially hostile) takeover of axis-shield plc;waterlogic plc on its £122m take private;daisy plc on its £494m take private;diurnal group plc on its £75m aim ipo;newriver retail limited on the imposition of a new english holding company, newriver reit, and its redomiciliation via a guernsey cancellation scheme of arrangement and move to the main market;newriver reit plc on its firm placing, placing and open offer raising £225m;investec on the £309m main market ipo of fdm group (holdings) plc;peel hunt on regional reit limited's £100m firm placing, placing, open offer and offer for subscription;integrafin holdings plc on its main market ipo resulting in a market cap of £650m and raising £178m for selling shareholders;capita plc on its £500m bid for xchanging plc;kuala lumpur kepong berhad on its £414m hostile bid for mp evans plc;daisy on its £165m takeover of alternative networks plc;teledyne technologies incorporated on its £620m bid for e2v technologies plc;altrad investment authority sas on its recommended cash offer for cape plc;sinclair pharma on its £167 million takeover by huadong medicine; anddairy crest on its £975 million takeover by saputo inc., Eversheds Sutherland (International) LLP